Skip To Main Content
Contact us
|
Help
Home
About
ADR
ADR Archives
Resources
Contact
Flash e-reader
Choose a chapter:
Introduction
Kidney
Pancreas
Liver
Intestine
Heart
Lung
Deceased Organ Donation
Allocation Policies
Appendix
Table Selection
Choose an organ:
All Organs
Kidney
Pancreas
Kidney/Pancreas
Heart
Lung
Heart/Lung
Intestine
Liver
Choose a group:
Choose a characteristic:
Requires
Adobe Acrobat Reader
Table 11.8
Adjusted Graft Survival, Heart Transplants
Survival at 3 Months, 1 Year, 5 Years, and 10 Years
3 Months
1 Year
5 Years
10 Years
(Tx 2007 - 2008)
(Tx 2007 - 2008)
(Tx 2003 - 2008)
(Tx 1998 - 2008)
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
N
%
Std. Err.
Total
All
4,222
93.2%
0.4%
4,222
88.4%
0.5%
12,409
74.0%
0.5%
23,276
54.5%
0.5%
Transplant Center State
Alabama
39
94.8%
3.6%
39
86.9%
5.4%
124
71.1%
4.6%
270
55.5%
4.0%
Arkansas
66
95.5%
2.5%
66
91.0%
3.5%
177
63.5%
4.4%
257
42.9%
5.6%
Arizona
92
93.7%
2.5%
92
90.5%
3.0%
250
73.9%
3.6%
394
58.1%
3.5%
California
541
94.7%
1.0%
541
90.2%
1.3%
1,595
76.4%
1.2%
2,852
55.0%
1.4%
Colorado
65
93.9%
2.9%
65
89.4%
3.8%
190
76.1%
3.4%
400
55.7%
3.4%
Connecticut
43
90.3%
4.5%
43
80.6%
6.1%
103
58.8%
5.8%
223
38.7%
4.6%
District of Columbia
7
85.5%
12.5%
7
85.5%
12.5%
39
80.1%
6.2%
77
65.6%
6.4%
Delaware
4
73.3%
20.0%
4
73.3%
20.0%
6
64.8%
18.2%
6
64.5%
18.2%
Florida
290
94.3%
1.3%
290
87.9%
1.9%
813
76.3%
1.8%
1,410
57.5%
2.0%
Georgia
90
90.0%
3.1%
90
85.6%
3.7%
254
67.8%
3.6%
483
54.2%
3.0%
Hawaii
3
100.0%
0.0%
3
68.6%
20.3%
7
61.7%
19.7%
17
44.8%
16.1%
Iowa
18
+
+
18
+
+
57
89.2%
4.7%
115
67.1%
5.8%
Illinois
166
94.6%
1.7%
166
91.0%
2.2%
437
72.2%
2.8%
783
56.0%
2.7%
Indiana
77
92.0%
3.1%
77
77.4%
4.8%
232
63.0%
3.8%
445
43.9%
3.5%
Kansas
13
77.4%
11.0%
13
77.4%
11.0%
40
77.1%
7.1%
68
40.6%
8.9%
Kentucky
35
87.6%
5.7%
35
84.6%
6.3%
136
71.7%
4.5%
300
46.1%
3.9%
Louisiana
42
93.4%
3.6%
42
86.8%
5.0%
146
71.7%
4.1%
429
50.6%
3.1%
Massachusetts
153
92.8%
2.1%
153
88.2%
2.6%
363
78.1%
2.9%
655
59.9%
2.9%
Maryland
89
87.7%
3.5%
89
77.6%
4.4%
204
70.1%
3.6%
330
48.0%
4.1%
Michigan
99
94.9%
2.2%
99
92.8%
2.6%
308
79.6%
2.5%
615
52.0%
3.1%
Minnesota
112
96.3%
1.8%
112
93.5%
2.4%
356
78.4%
2.6%
599
62.3%
3.0%
Missouri
171
91.6%
2.1%
171
85.1%
2.8%
436
75.0%
2.4%
781
53.6%
2.7%
Mississippi
18
94.5%
5.2%
18
94.5%
5.2%
51
64.8%
7.9%
109
53.8%
6.1%
North Carolina
163
93.3%
2.0%
163
90.2%
2.3%
475
71.2%
2.5%
900
50.5%
2.6%
Nebraska
25
96.1%
3.8%
25
92.2%
5.2%
54
74.5%
6.5%
86
37.9%
8.9%
New Jersey
92
96.8%
1.8%
92
92.4%
2.7%
264
80.2%
2.9%
423
51.2%
4.5%
New Mexico
0
-
-
0
-
-
0
-
-
20
54.3%
10.9%
New York
270
94.6%
1.4%
270
87.7%
2.0%
861
73.2%
1.7%
1,586
57.8%
1.8%
Ohio
175
90.7%
2.2%
175
86.1%
2.6%
591
75.4%
2.1%
1,255
54.2%
2.0%
Oklahoma
22
90.8%
6.1%
22
86.2%
7.2%
107
63.4%
5.5%
256
46.4%
4.1%
Oregon
35
94.0%
4.1%
35
91.0%
4.9%
115
80.5%
4.6%
236
61.6%
4.8%
Pennsylvania
353
93.0%
1.3%
353
88.4%
1.7%
1,011
73.6%
1.7%
1,975
53.9%
1.6%
Puerto Rico
21
+
+
21
+
+
77
76.5%
5.6%
111
56.8%
8.8%
South Carolina
39
94.6%
3.7%
39
91.9%
4.4%
116
77.8%
4.6%
234
63.3%
4.5%
Tennessee
99
86.0%
3.4%
99
82.0%
3.8%
298
73.7%
3.0%
605
50.5%
3.0%
Texas
368
93.2%
1.3%
368
88.4%
1.6%
1,059
67.8%
1.8%
1,949
51.8%
1.6%
Utah
67
95.5%
2.5%
67
94.0%
2.9%
207
82.3%
3.2%
350
61.1%
4.2%
Virginia
111
91.9%
2.6%
111
89.2%
2.9%
319
73.9%
2.8%
609
51.8%
3.0%
Washington
81
96.3%
2.1%
81
95.1%
2.4%
236
84.6%
2.7%
434
74.1%
2.8%
Wisconsin
68
83.5%
4.5%
68
79.0%
4.9%
295
75.7%
2.8%
629
55.9%
2.8%
Source: OPTN/SRTR Data as of October 1, 2010.
(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.
Cohorts are transplants performed during the years listed at the top of the table.
Graft survival follows individual transplants until graft failure.
Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.
Center volume = Center's yearly transplants performed during the base period, based on heart and heart-lung transplants.
Multi-organ transplants are excluded.
Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.